IRIDEX Corporation Book Value 2011-2026 | IRIX

Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.

What is included in book value

Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.

Features of the metric

Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account.
Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market.
Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors.
Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.

Annual Book Value IRIDEX Corporation

2026	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.92 M	2.1 M	9.52 M	17.2 M	17.4 M	-	22.7 M	30 M	30.5 M	33.7 M	33.7 M	-	25.9 M	21.9 M	19.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
33.7 M	2.1 M	20.7 M

Quarterly Book Value IRIDEX Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
4.68 M	6.06 M	6.85 M	2.1 M	2.62 M	4.25 M	6.49 M	9.52 M	12.1 M	13.4 M	15.9 M	17.2 M	18.1 M	19.4 M	21.3 M	17.4 M	25.3 M	26.9 M	25.6 M	-	17.3 M	18.8 M	21.1 M	22.7 M	22.7 M	22.7 M	22.7 M	30 M	30 M	30 M	30 M	30.5 M	30.5 M	30.5 M	30.5 M	39.2 M	39.2 M	39.2 M	39.2 M	33.7 M	32.8 M	33.2 M	34 M	-	25.6 M	25.7 M	26.6 M	25.9 M	25.9 M	25.9 M	25.9 M	21.9 M	21.9 M	21.9 M	21.9 M	22.4 M	22.4 M	22.4 M	22.4 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
39.2 M	2.1 M	22.7 M

Book Value of other stocks in the Medical devices industry

Issuer	Book Value	Price	% 24h	Market Cap	Country
GenMark Diagnostics, Inc. GNMK	196 M	-	-	$ 1.77 B	USA
Acutus Medical AFIB	-879 K	-	-26.83 %	$ 2.62 M	USA
AdaptHealth Corp. AHCO	1.53 B	$ 11.94	-1.08 %	$ 1.61 B	USA
Allied Healthcare Products AHPI	19.7 M	-	3.58 %	$ 2.21 M	USA
Lianluo Smart Limited LLIT	272 M	-	24.59 %	$ 44.8 M	China
ClearPoint Neuro CLPT	28 M	$ 9.07	-3.3 %	$ 257 M	USA
Obalon Therapeutics, Inc. OBLN	25.5 M	-	-5.86 %	$ 30.6 M	USA
Bruker Corporation BRKR	1.82 B	$ 36.67	-0.19 %	$ 5.46 K	USA
Apollo Endosurgery APEN	32.6 M	-	-	$ 475 M	USA
FONAR Corporation FONR	146 M	$ 18.58	-0.11 %	$ 122 M	USA
EDAP TMS S.A. EDAP	56.9 M	$ 3.4	-1.73 %	$ 127 M	France
Globus Medical GMED	4.57 B	$ 90.0	1.58 %	$ 12.2 B	USA
CryoLife, Inc. CRY	58.1 M	-	-4.14 %	$ 702 M	USA
Avinger AVGR	-6.2 M	-	-20.74 %	$ 369 K	USA
Align Technology ALGN	3.85 B	$ 166.87	-2.91 %	$ 12.5 B	USA
CHF Solutions, Inc. CHFS	6.23 M	-	1.15 %	$ 34.5 M	USA
AxoGen AXGN	129 M	$ 30.99	-5.06 %	$ 1.43 B	USA
Axonics Modulation Technologies AXNX	570 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	27.7 M	-	1.37 %	$ 20.5 M	USA
Soliton, Inc. SOLY	243 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	2.61 B	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	229 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	30.4 M	-	-	$ 462 M	USA
Neovasc NVCN	52.2 M	-	-	$ 111 M	Canada
Butterfly Network BFLY	169 M	$ 4.05	-1.94 %	$ 857 M	USA
Intersect ENT, Inc. XENT	550 M	-	-	$ 955 M	USA
Cytosorbents Corporation CTSO	5.9 M	$ 0.61	3.37 %	$ 38 M	USA
BIOLASE BIOL	1.96 M	-	-13.19 %	$ 166 K	USA
Delcath Systems DCTH	111 M	$ 9.67	-0.31 %	$ 346 M	USA
Helius Medical Technologies HSDT	2.35 M	$ 1.83	-3.68 %	$ 1.11 M	USA
BioSig Technologies BSGM	133 M	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	43.7 B	$ 61.86	-1.12 %	$ 91.6 B	USA
Alphatec Holdings ATEC	791 M	$ 11.03	0.55 %	$ 1.66 B	USA
Integra LifeSciences Holdings Corporation IART	1.55 B	$ 9.33	0.21 %	$ 719 M	USA
CONMED Corporation CNMD	1.03 B	$ 34.54	1.35 %	$ 1.07 B	USA
Integer Holdings Corporation ITGR	1.75 B	$ 85.11	-0.61 %	$ 2.96 B	USA
Edwards Lifesciences Corporation EW	10.3 B	$ 80.84	-0.43 %	$ 47.3 B	USA
Inspire Medical Systems INSP	781 M	$ 54.42	0.52 %	$ 1.6 B	USA
OrthoPediatrics Corp. KIDS	347 M	$ 15.76	-1.13 %	$ 370 M	USA
LENSAR LNSR	-12.2 M	$ 5.63	-4.41 %	$ 67.3 M	USA
Conformis CFMS	54.2 M	-	-	$ 16.4 M	USA
Medtronic PLC MDT	48.3 B	$ 86.42	0.15 %	$ 111 B	USA
Cardiovascular Systems CSII	249 M	-	0.15 %	$ 844 M	USA
Cutera CUTR	-172 M	-	-10.19 %	$ 1.99 M	USA
Myomo MYO	11.4 M	$ 0.68	-2.9 %	$ 28.5 M	USA
Dynatronics Corporation DYNT	3.26 M	-	14.99 %	$ 929 K	USA
Eargo EAR	101 M	-	-	$ 10.2 M	USA
Orthofix Medical OFIX	450 M	$ 11.71	-0.51 %	$ 464 M	Curacao
Second Sight Medical Products EYES	15.7 M	-	-0.97 %	$ 54.4 M	USA